NOMANESIT 85 mg/500 mg, film-coated tablet 9 tablets
Active ingredients: Naproxen, Naproxen sodium, Sumatriptan succinate, Sumatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet9 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOMANESIT 85 mg/500 mg comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium OPA : polyamide orienté de 9 comprimé(s)
- Marketing authorisation holder
- ORION CORPORATION
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67435682CIP73029243CIP133400930292433Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NAPROXÈNEcomprimé | 457 mg · un comprimé | FT |
| NAPROXÈNE SODIQUEcomprimé | 500 mg · un comprimé | SA |
| SUCCINATE DE SUMATRIPTANcomprimé | 119 mg · un comprimé | SA |
| SUMATRIPTANcomprimé | 85 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.